HFSA Membership Spotlight: Dr. Emmanuel Buys
Background: Dr. Emmanuel (Manu) Buys, Ph.D., is a molecular biologist who studies cyclic guanosine monophosphate (cGMP)-signaling in a variety of (patho-) physiological processes both in animal models and in human subjects. His ultimate goal is to develop and translate reagents that stimulate cGMP signaling as therapeutics for a wide range of diseases (including cardiovascular disease and glaucoma).
His background as an expert in NO-sGC-cGMP signaling and as a molecular biologist with experience in animal models of human physiology and disease led him to serve as a co-PI with Dr. Warren Zapol, Dr. Allyson Hindle, and Dr. Daniel Costa on a project (funded by the National Science Foundation, and including a deployment to McMurdo Antarctica to collect biologically relevant samples) to test the hypothesis that altered NO-cGMP signaling underlies the capability of Antarctic Weddell seals to withstand severe bouts of hypoxia as they dive for prolonged periods of time.
Spotlight story: In Dr. Buys’ own words about his project:
The Weddell seal is a champion diving mammal. The physiology that permits these animals to sustain extended breath-hold periods and survive the extreme pressure of diving deep allows them to thrive in icy Antarctic waters. Key elements of their physiological specializations to breath-hold diving are their ability for remarkable adjustment of their heart and blood vessel system, coordinating blood pressure and flow to specific body regions based on their metabolic requirements, and their ability to sustain periods without oxygen. Identifying the details of these strategies has tremendous potential to better inform human medicine, helping us to develop novel therapies for cardiovascular trauma (e.g. stroke, heart attack) and diseases associated with blunted oxygen delivery to tissues (e.g. pneumonia, sepsis, or cancer). The goal of this project, collaboratively led by Dr. Manu Buys, Dr. Allyson Hindle, and Dr. Warren Zapol at MGH and Dr. Dan Costa at UCSC) is to document specific genes that control these cardiovascular adjustments in seals, and to compare their abundance and activity with humans, a collaboration with Dr. Jessica Alföldi, Dr. Kerstin Lindblad-Toh and their colleagues at the Broad Institute. Specifically, the investigators will study the signaling pathway that coordinates this response. They will also use tissue samples to generate cultured cells from Weddell seals that can be used to study the molecular effects of low oxygen conditions in the laboratory. The project will further the NSF goals of training new generations of scientists and of making scientific discoveries available to the general public. The project will train a pre-veterinary student researcher will conduct public outreach via a center for community health improvement, a multicultural affairs office, and the New England Aquarium.
The goal of this study is to unravel the molecular mechanisms underlying the dive response. A hallmark of the dive response is tissue-specific vascular system regulation, likely resulting from variation in both nerve function and in production of local signaling molecules produced by blood vessel cells. The investigators will use emerging genomic information to begin to unravel the genetics underling the redistribution of the circulation. They will also directly test the hypothesis that modifications in the signaling system prevent local blood vessel changes under low oxygen conditions, thereby allowing the centrally mediated diving reflex to override local physiological responses and to control the amount of tension in the muscle inside the walls of blood vessels in Weddell seals. They will perform RNA-sequencing of Weddell seal tissues and use the resulting sequence, along with information from other mammals such as dog, to obtain a full gene annotation (identifying locations of all genes and determining what they do) of the Weddell seal, facilitating comparative and species-specific genomic research. They will also characterize the intracellular signaling system in relevant tissues and they will generate a Weddell seal pluripotent stem cell line which should be a valuable research tool for cell biologists, molecular biologists and physiologists that will allow them to further test their hypotheses. In addition, they will study the Weddell seal microbiome (a collaboration with Dr. Nadim Jose Ajami and Dr. Joseph Petrosino at Baylor College of Medicine, Fatty acid transport and metabolism (a collaboration with Dr. Michael Fitzgerald and Dr. Slim Sassi at MGH, and Dr. Eduard Braun at the University of Florida), the effect of cortisol on the inflammatory response (a collaboration with Dr. Aranya Bagchi), and protein complement activity (a collaboration with Mystic Aquarium). It is expected that the proposed studies will advance our knowledge of the biochemical and physiological adaptations that allow the Weddell seal to thrive in the Antarctic environment.
HFSA is pleased to spotlight Dr. Buys and his work that will hopefully play a role in aiding future human heart failure patients from his research on the cardiovascular functions of the Weddell Seal!
Read more about Dr. Buys’ progress and project updates through the group’s blog posts.